{
    "organizations": [],
    "uuid": "c99df5d2dd87e3d4d383e19c350150ce32af0762",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novo-nordisk-says-glp-1-drug-ozemp/brief-novo-nordisk-says-glp-1-drug-ozempic-included-in-u-s-express-script-2018-formulary-list-idUSS3N1PR01U",
    "ord_in_thread": 0,
    "title": "BRIEF-Novo Nordisk Says GLP-1 Drug Ozempic Included In U.S. Express Script 2018 Formulary List",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "February 21, 2018 / 3:00 PM / in 3 minutes BRIEF-Novo Nordisk Says GLP-1 Drug Ozempic Included In U.S. Express Script 2018 Formulary List Reuters Staff 1 Min Read Feb 21 (Reuters) - NOVO NORDISK: * SAYS ITS GLP-1 DRUG OZEMPIC HAS BEEN INCLUDED IN U.S. EXPRESS SCRIPT 2018 FORMULARY LIST FURTHER COMPANY COVERAGE: (Reporting by Jacob Gronholt-Pedersen)",
    "published": "2018-02-21T16:59:00.000+02:00",
    "crawled": "2018-02-21T17:14:35.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "february",
        "pm",
        "minute",
        "nordisk",
        "say",
        "drug",
        "ozempic",
        "included",
        "express",
        "script",
        "formulary",
        "list",
        "reuters",
        "staff",
        "min",
        "read",
        "feb",
        "reuters",
        "novo",
        "nordisk",
        "say",
        "drug",
        "ozempic",
        "included",
        "express",
        "script",
        "formulary",
        "list",
        "company",
        "coverage",
        "reporting",
        "jacob"
    ]
}